These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7047111)

  • 1. Recovery from decompensated non-insulin-dependent diabetes mellitus: studies of C-peptide secretion.
    Rendell M; Zarriello J; Drew HM; Dranbauer B; Wilson G; Waud J; Ross D
    Diabetes Care; 1981; 4(3):354-9. PubMed ID: 7047111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C-peptide response to oral glucose in low insulin responders, subdiabetic, and diabetic subjects.
    Toyota T; Kudo M; Abe K; Goto Y
    Tohoku J Exp Med; 1977 Feb; 121(2):99-104. PubMed ID: 847746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal C-peptide in the discrimination of type I from type II diabetes.
    Webb PG; Bonser AM
    Diabetes Care; 1981; 4(6):616-9. PubMed ID: 6751738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin therapy in relation to circulating C-peptide levels.
    Beischer W; Kerner W; Raptis S; Keller L; Beischer B; Pfeiffer EF
    Diabetes; 1978; 27 Suppl 1():235-40. PubMed ID: 415925
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery.
    Block MB; Mako ME; Steiner DF; Rubenstein AH
    J Clin Endocrinol Metab; 1972 Sep; 35(3):402-6. PubMed ID: 4626271
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
    Block MB; Rosenfield RL; Mako ME; Steiner DF; Rubenstein AH
    N Engl J Med; 1973 May; 288(22):1144-8. PubMed ID: 4633551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 10. Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Binder C; Faber OK
    Q J Med; 1979 Apr; 48(190):343-60. PubMed ID: 574299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients.
    Osei K; Falko JM; O'Dorisio TM; Adam DR; Cataland S
    Diabetes Care; 1984; 7(5):442-6. PubMed ID: 6389058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma insulin and C-peptide in relation to glucose intolerance in middle-aged men.
    Malmquist J; Lindgärde F; Eriksson KF; Johansson E
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):262-5. PubMed ID: 7051718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenetic relationship between insulin resistance, insulin secretion and impaired glucose tolerance in patients with obesity].
    Abdurakhmanova AM; Kosovskiĭ MI; Rakhimov NR; Guliamov TD
    Probl Endokrinol (Mosk); 1988; 34(2):21-4. PubMed ID: 3293029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
    Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
    Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and C-peptide secretion in non-insulin-dependent diabetes mellitus and its response to dietary therapy.
    Beatty OL; Bell PM; Hadden DR; Atkinson AB; Kennedy L
    QJM; 1995 Apr; 88(4):257-62. PubMed ID: 7796075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 20. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.